Alum Jesse Keicher‘s company, Symmune Therapeutics, popped up in the news recently! The biotechnology startup focuses on the treatment and prevention of pulmonary infections and pulmonary diseases.
Keicher received his bachelor’s degree in Biochemistry at the University of Oregon in 1999, and went on to earn a UO master’s degree in chemistry in 2000.
Read more here:
Durham-based Symmune Therapeutics Raises $125,000